Trends in hormone therapy use before and after publication of the Women's Health Initiative trial
- 1 September 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Menopause
- Vol. 16 (5), 1061-1064
- https://doi.org/10.1097/gme.0b013e3181a02b44
Abstract
Objective: The aim of this study was to assess the impact of the scientific evidence reported by Women's Health Initiative (WHI) trial on hormone therapy (HT) use in a 10-year follow-up retrospective cohort of women participating in a breast cancer screening program. Methods: Between 1998 and 2007, a retrospective cohort of participants in a population-based breast cancer screening program in the city of Barcelona (Catalonia, Spain) was assessed. The study population consisted of 50,918 women. Trends in current HT use and the annual rate of new users were analyzed by age group. Results: From 1998, successive annual increases were found in the prevalence levels of HT use in all age groups. In 2002, the prevalence peaked at 11% in 50- to 54-year-olds and at 10.1% in 55- to 59-year-olds, followed by a sudden reversal and a progressive decrease. In 2007, 5 years after the publication of the WHI trial, the HT use decreased by 89.1% in 50- to 54-year-olds, 87.5% in 55- to 59-year-olds, 84.6% in 60- to 64-year-olds, and 66.0% in 65- to 69-year-olds. The percentage of new users also fell substantially after 2002. Conclusions: HT use decreased during the 5 years after the publication of the WHI. This reduction was especially marked in the first 2 years, when the decrease in new treatments exceeded the number of continuations. In the following 3 years, the decrease was approximately equal in both groups.Keywords
This publication has 18 references indexed in Scilit:
- Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publicationPharmacoepidemiology and Drug Safety, 2006
- Recent Declines in Hormone Therapy Utilization and Breast Cancer Incidence: Clinical and Population-Based EvidenceJournal of Clinical Oncology, 2006
- Recent reversal of trends in hormone therapy use in a European populationMenopause, 2006
- Estimated numbers of postmenopausal women treated by hormone therapy in FranceMaturitas, 2005
- The impact of clinical trials on the use of hormone replacement therapyJournal of General Internal Medicine, 2005
- National Use of Postmenopausal Hormone TherapyPublished by American Medical Association (AMA) ,2004
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Recommendations and RationaleAnnals of Internal Medicine, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJama-Journal Of The American Medical Association, 2002
- RETIRED: Hormone Replacement Therapy and Cardiovascular DiseaseJournal of Obstetrics and Gynaecology Canada, 2002